ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
Thecure
|
42 |
17K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
42
|
17K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive Feedback received from Spanish Medicines Agency
|
|
Thecure
|
4 |
2.0K |
18 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4
|
2.0K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Thecure
|
56 |
29K |
11 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
29K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Thecure
|
56 |
29K |
3 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
56
|
29K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
12 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appointment of Non-Executive Director
|
|
Thecure
|
3 |
1.8K |
10 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
3
|
1.8K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
Thecure
|
24 |
8.4K |
18 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
24
|
8.4K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appointment of Non-Executive Director
|
|
Thecure
|
3 |
1.8K |
9 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
3
|
1.8K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
34 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
743
|
328K
|
34
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notification regarding unquoted securities - IMM
|
|
Thecure
|
3 |
1.6K |
9 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
3
|
1.6K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
15 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Proposed issue of securities - IMM
|
|
Thecure
|
2 |
1.3K |
11 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
2
|
1.3K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
743
|
328K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
15 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ESMO 2023 abstracts
|
|
Thecure
|
10 |
5.1K |
4 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
10
|
5.1K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
11 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
743
|
328K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
5 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
743
|
328K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
6 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
13 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
743
|
328K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
743 |
328K |
6 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
743
|
328K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Thecure
|
57 |
25K |
9 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Thecure
|
57 |
25K |
5 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Promising New Data in 1st line NSCLC from INSIGHT-003 Trial
|
|
Thecure
|
9 |
5.0K |
21 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
9
|
5.0K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change of Director's Interest Notice - R Howard
|
|
Thecure
|
13 |
5.1K |
15 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
13
|
5.1K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
1 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
8 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Application for quotation of securities - IMM
|
|
Thecure
|
15 |
4.2K |
13 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
15
|
4.2K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Thecure
|
2.6K |
1.0M |
6 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
IMM vs IMU
|
|
Thecure
|
11 |
3.6K |
4 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
11
|
3.6K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
a guide of sorts
|
|
Thecure
|
25 |
11K |
2 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
25
|
11K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
Thecure
|
47 |
28K |
12 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
47
|
28K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
Thecure
|
47 |
28K |
15 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
47
|
28K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
382 |
191K |
7 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
382
|
191K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Thecure
|
382 |
191K |
13 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
382
|
191K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Thecure
|
43 |
21K |
6 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
43
|
21K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notification regarding unquoted securities - IMM
|
|
Thecure
|
1 |
707 |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
1
|
707
|
0
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
Thecure
|
88 |
34K |
3 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to present final AIPAC Overall Survival data at SITC
|
|
Thecure
|
18 |
8.8K |
8 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
18
|
8.8K
|
8
|
|
ASX - By Stock
|
IMM |
Memorial Sloan Kettering Validation of LAG-3 impact
|
|
Thecure
|
2 |
1.3K |
26 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
2
|
1.3K
|
26
|
|
ASX - By Stock
|
IMM |
Re:
Mystified
|
|
Thecure
|
63 |
30K |
4 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
63
|
30K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
orphan drug definitions...
|
|
Thecure
|
47 |
17K |
2 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
47
|
17K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO
|
|
Thecure
|
260 |
101K |
6 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
260
|
101K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Thecure
|
127 |
62K |
10 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
127
|
62K
|
10
|
|
ASX - By Stock
|
IMM |
Data from BMS and COVID
|
|
Thecure
|
4 |
2.2K |
16 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
4
|
2.2K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Recruitment of head & neck cancer patients completed for ph2
|
|
Thecure
|
44 |
25K |
0 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
44
|
25K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Recruitment of head & neck cancer patients completed for ph2
|
|
Thecure
|
44 |
25K |
5 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
44
|
25K
|
5
|
|